Lord, Abbett & Co. LLC Curis Inc Transaction History

Lord, Abbett & Co. LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$2.31 - $5.13 $2.51 Million - $5.57 Million	-1,086,103 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$4.45 - $8.09 $10.7 Million - $19.5 Million	-2,407,462 Reduced 68.91%	1,086,103 $5.17 Million
Q3 2021 Nov 09, 2021	SELL	$6.94 - $8.85 $627,438 - $800,119	-90,409 Reduced 2.52%	3,493,565 $27.4 Million
Q2 2021 Aug 11, 2021	BUY	$7.45 - $16.27 $19.6 Million - $42.8 Million	2,631,910 Added 276.44%	3,583,974 $28.9 Million
Q1 2021 May 11, 2021	BUY	$8.78 - $12.8 $8.36 Million - $12.2 Million	952,064 New	952,064 $10.8 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.